Pharmaceutical Companies in Sydney
A majority of the world’s leading pharmaceutical companies have their Australian headquarters in Sydney and have been conducting their clinical trials here for many years, taking advantage of our excellent infrastructure. About half of Australia’s pharmaceutical production capacity is located in Sydney.
Some of the major multinational pharmaceutical companies which operate manufacturing facilities in NSW include Merck Sharp and Dohme, AstraZeneca, Pfizer and Roche.
Conducting Clinical Trials in Sydney
Australian hospitals and health care professionals are among the best in the world. Australian hospitals use the same treatment guidelines for diseases as the United States and European Union. With a strong focus on intellectual property protection, Australia’s stable business environment has contributed to the establishment of an ideal clinical trial destination.
Clinical trials can be conducted in Australia at a lower cost than in the United States, Canada and many European countries while maintaining the highest international standards.
The Australian regulatory authority (Therapeutic Goods Administration or TGA) has an FDA- (Food and Drug Administration) and EMEA- (European Agency for the Evaluation of Medicinal Products) compliant regulatory regime. Australia has a swift regulatory system, enabling study approval in 2 - 3 months.
The TGA stringently oversees all clinical trials. Its rulings are recognised and upheld by counterpart organisations world-wide. The TGA accepts data submitted from clinical trials conducted overseas as long as they follow Good Clinical Practice.
Experienced clinical trial staff guarantee that clinical trials routinely meet international regulatory requirements including those of the FDA and the International Conference on Harmonisation (ICH).
For more information, email info@clinicaltrials.org.au or call +61 2 8374 3569